$BIIB Company News Biogen results crush consensus 4:55

New Post Public Reply Private Reply Replies (0) Message Board

Aug 5, 2014 at 12:21 PM

$BIIB Company News

Biogen results crush consensus 4:55 p.m. July 23, 2014 - The Trading Deck
S&P 500 closes at record on strong earnings 4:23 p.m. July 23, 2014 - Anora Mahmudova
Apple, Intuitive power S&P 500 to record: stock market live blog recap 4:17 p.m. July 23, 2014 - blogs.marketwatch.com
Biogen rallies on earnings; Juniper slumps 10% 1:25 p.m. July 23, 2014 - Sue Chang
Biogen earnings: A lesson in how to boost an already pricey stock 10:49 a.m. July 23, 2014 - Russ Britt
Biogen Idec shares rally 12% 9:32 a.m. July 23, 2014 - Sue Chang
Biogen Idec shares up 7% in premarket trade after earnings 7:39 a.m. July 23, 2014 - Ciara Linnane
Biogen Idec's profit, sales blow past estimates 7:20 a.m. July 23, 2014 - MarketWatch.com
Biogen Idec shares rally 5.4% in premarket trade after earnings 6:53 a.m. July 23, 2014 - Tomi Kilgore
One lesson for investors from the 1990s bubble 3:13 p.m. June 19, 2014 - The Trading Deck
Tyson rallies after jumping into Hillshire chase 3:44 p.m. May 29, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - Russ Britt
Scouring the moonscape for leading stocks 3:02 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground 4:58 p.m. April 14, 2014 - Russ Britt
Herbalife sinks on probe fears; Zoe’s surges on debut 4:37 p.m. April 11, 2014 - Sue Chang

Five Large Caps With Earnings Growth Of 25% Or More 35 min ago - TheStreet.com
3 Stocks Reiterated As A Buy: MA, UNH, BIIB 11:14 a.m. Aug. 4, 2014 - TheStreet.com
Acorda Beats on Q2 Earnings & Revenues, Maintains View - Analyst Blog 9:20 a.m. Aug. 4, 2014 - Zacks.com
Christopher James Turns A Clinical Eye On Biotechs With High Reward Potential 7:36 a.m. Aug. 4, 2014 - Seeking Alpha
Biotech Gets A Lift On Popular Drug, Strong Pipeline 6:13 p.m. Aug. 1, 2014 - Investors Business Daily
Stock Market News for August 01, 2014 - Market News 10:10 a.m. Aug. 1, 2014 - Zacks.com
Isis set for milestone payment from Biogen 8:32 a.m. Aug. 1, 2014 - Seeking Alpha
Amgen Makes the Cut 12:25 p.m. July 31, 2014 - Barrons.com
Stock Market News for July 31, 2014 - Market News 10:10 a.m. July 31, 2014 - Zacks.com
Increased Earnings Estimates Seen for Biogen Idec (BIIB): Can It Move Higher? - Tale of the Tape 8:57 a.m. July 31, 2014 - Zacks.com
Biotech Valuations Are Low Not Stretched. Here's Why. 8:35 a.m. July 31, 2014 - TheStreet.com
Cramer's Lightning Round - 6 Biotech Picks (7/30/14) 6:35 a.m. July 31, 2014 - Seeking Alpha
Biotech Stock Roundup: Gilead's Sovaldi & Biogen's Tecfidera Impressive Run Continues - Analyst Blog 12:04 p.m. July 30, 2014 - Zacks.com
Undervalued Biotech Stocks Beat the Index 10:42 a.m. July 30, 2014 - Barrons.com
Stock Market News for July 30, 2014 - Market News 10:10 a.m. July 30, 2014 - Zacks.com
Biogen Idec (BIIB) Highlighted As Momo Momentum Stock 10:00 a.m. July 30, 2014 - TheStreet.com
3 Stocks Reiterated As A Buy: IBM, GS, BIIB 3:44 p.m. July 29, 2014 - TheStreet.com
Can Biogen Idec Take Wing With Tecfidera? 2:56 p.m. July 29, 2014 - Seeking Alpha
Biogen Idec Should Have A Strong Floor Of Support At These Levels 10:23 a.m. July 29, 2014 - Seeking Alpha
Ken Fisher's Top Increaes of the Second Quarter 6:06 p.m. July 28, 2014 - GuruFocus.com

Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth 9:13 a.m. Today - PR Newswire - PRF
Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA Biomarkers in Multiple Sclerosis 8:00 a.m. Today - PR Newswire - PRF
BioMed Realty Trust To Webcast Investor Day 2014 8:00 a.m. Aug. 4, 2014 - PR Newswire - PRF
Favorable Court Ruling, Quarterly Performance Reviews, Acquisition Completion, and Contract Renewals - Research Reports on Mylan, Biogen, Medtronic, UnitedHealth and Covidien 9:20 a.m. Aug. 1, 2014 - PR Newswire - PRF
RBCC 3D Bioprinting Partner Awarded Prestigious Grant 6:54 a.m. July 31, 2014 - BusinessWire - BZX
Proteostasis Therapeutics Announces Achievement of Preclinical Milestone in Neurodegenerative Diseases Collaboration With Biogen Idec 5:30 a.m. July 30, 2014 - Marketwire
PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis 11:41 a.m. July 23, 2014 - BusinessWire - BZX
Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 12:00 p.m. July 22, 2014 - PR Newswire - PRF
Technical Update, Leadership Appointments, Therapy Approvals, Notifications, and Clinical Trial Results - Analyst Notes on Biogen, Medivation, BioMarin, Acorda and Targacept 8:40 a.m. July 17, 2014 - PR Newswire - PRF
Biogen Idec and Yahoo Health Spotlight Visionaries Whose Work Benefits People with Multiple Sclerosis (MS) 8:01 a.m. July 16, 2014 - BusinessWire - BZX
Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec 5:55 a.m. July 7, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
RBCC Developing New Tech to Help Prevent Deaths From Prescription Overdoses 5:00 a.m. July 2, 2014 - BusinessWire - BZX
Biogen Idec to Report Second Quarter 2014 Financial Results on July 23, 2014 4:01 p.m. June 30, 2014 - BusinessWire - BZX
Critical Alerts For Vertex Pharmaceuticals, Dollar Tree, Avis, Ryder, and Biogen Released By InvestorsObserver 9:31 a.m. June 25, 2014 - PR Newswire - PRF
True North Therapeutics Announces $22 Million Series A Financing 7:00 a.m. June 17, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec 7:00 a.m. June 17, 2014 - PR Newswire - PRF
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple Sclerosis 7:30 a.m. June 16, 2014 - BusinessWire - BZX
Sobi to review preclinical data to potentially add future haemophilia A candidate to collaboration agreement with Biogen Idec 2:01 a.m. June 16, 2014 - Thomson Reuters ONE
One Year Post-Launch, All Surveyed U.S. Neurologists Report Having Clinical Experience with Biogen Idec's Tecfidera for the Treatment of Multiple Sclerosis 12:00 p.m. June 12, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vertice P2P Aims to Transform Procurement Efficiency

Vertice Dives Deeper into the Procurement Game Grab a coffee and let's talk some procurement—one of the least sexy, yet utterly essential parts of any operation. Vertice's latest announcement is anything but mundane. They're spiraling deeper into the procurement universe with their new Procure-to-Pay (P2P) capability, a bold expansion from their Intake-to-Procure (I2P)...

PKGD Group's Agave Spirits Surge 56% in 2026 Growth'

PKGD Group's Impressive Growth Story Sometimes you read a report and it genuinely knocks the wind out of you—not because it’s unusual, but because it’s rare to see such robust numbers in a market that ain't exactly all sunshine and rainbows. PKGD Group, the brain behind some damn fine agave spirits, decided to take no prisoners this year, reporting a jaw-dropping...

D-Wave Quantum Faces Class Action Over Stock Missteps

A lawsuit has been lobbed at D-Wave Quantum Inc., and Wall Street's abuzz over it. Investors who've dabbled in NASDAQ:QBTS between February 26 and August 25, 2026 might be eligible to hop onto this class action lawsuit train. The beef is all about allegedly misleading statements concerning the company's operational outlook, and it's a familiar song and dance when a...

AMTD Digital's Half-Year Results Stir Investor Interest

AMTD Digital Warming Up for a Busy Quarter Some things just catch the wind differently in the market, and when a heavyweight like AMTD Digital starts talking numbers, everybody perks up. They're gearing up to drop their half-year financials, ready to roll out at the stroke of midnight on October 23rd, and investor ears across the globe are pricked for what’s coming down...

Grid Hurdles Stalling Industrial Heat's Future Growth

The Grid's the New Ball and Chain Now that we're done fiddling with tech, let's talk grid. The industrial players itching to switch to electric heat have found a new villain: the grid. You'd think with resistance heating, electric boilers, electric arc furnaces, and the whole shebang ready to roll, it’d be a smooth ride. But nope, the bottleneck's the bloodstream...

Doximity Lawsuit: Investors Face November Deadline

Hard Knocks for Doximity Investors Alright, so this isn't the place I usually find myself at that hour, but we're living in wild times if you're clinging to Doximity (NYSE:DOCS) shares. Listen up, because those lawyers are chiming in and they ain't just whistling Dixie. If you bought into DOCS between August 2024 and May 2026 and watched your investment bleed red ink,...

Endeavour and Trevi Turn Data Centers Into Water Sources

Turning Data Centers Into Wells If you'd told me data centers could double as water sources, I'd have laughed you off. But this week brings us a game-changing partnership between Endeavour and Trevi Systems. They're using the waste heat from data centers to create clean water, tackling water scarcity in the process. Imagine this: for every megawatt of computing power, up...

Vector Responds to HHS Call for Peptide Regulation

An Unexpected Turn in the Peptide Arena Whew, talk about a curveball in the therapeutics world. When U.S. Health and Human Services Secretary Robert F. Kennedy Jr. hit the airwaves on October 20, 2026, and talked about creating a regulated peptide marketplace, heads across the industry snapped to attention. Naturally, Vector Science and Therapeutics Corp. (TSXV: PAIN)...

Greenland Energy Board Reshuffle: McIllree Exits

A Change in Greenland Energy's Lineup Well, folks, the wheel keeps turning at Greenland Energy Company (NASDAQ:GLND). Roderick McIllree has decided to step off the Board of Directors' carousel, effective immediately. And nope, there wasn't a classic showdown or any disagreement on the table. This exit is as drama-free as they come—just him stepping aside, leaving the...

Unpacking the Sonic NEXT S13: A Toolbox Evolution

An All-in-One Solution Rolls In Listen up, gearheads and wrench-turners. Sonic Tools USA isn’t messing around with their newest release, the Sonic NEXT S13 toolbox. If you're tired of wrestling stubborn storage or losing track of your tools, this might just be what the shop ordered. Built to endure the tough grind of workshops from aviation to auto repair, the S13 is...